Bacteriophages of the Human Gut: The Known Unknown of the Microbiome
The exact retatrutide dosage depends on the clinical protocol, with treatment typically starting at a lower dose before progressing according to the planned retatrutide dosing schedule under medical supervision
In the multiple-dose trial, eligible subjects were healthy males, aged 1864 years, with a BMI of 20.029.9 kg/m 2 , and males with T2D diagnosed within the last 10 years, treated with diet and exercise and/or metformin, aged 1864 years, with a BMI of 20.037.0 kg/m 2 and glycosylated haemoglobin (HbA 1c ) of 6.59.0%
Alarmingly, this trend is growing and increasingly affecting younger populations at an accelerating rate [2]
Retatrutide targets three receptors: GLP-1, GIP, and glucagon
The medication slows gastric emptying by activating GLP-1 receptors throughout the gastrointestinal tract, causing delayed stomach-to-intestine transit